Fatores que explicam a percepção da efetividade da avaliação do estágio probatório em uma instituição pública federal

Considerando que o contexto social exerce influência sobre a efetividade da avaliação de desempenho (Levy; Williams, 2004) e a escassez do tema em pesquisas científicas, este artigo busca identificar que fatores explicam a percepção da efetividade da avaliação do estágio probatório. A hipótese é de que elementos contextuais são mais importantes do que variáveis individuais (Santos, 2005). A pesquisa utilizou um survey entre 24 de novembro e 30 de dezembro de 2015, com 550 servidores da Universidade Federal de Pernambuco. A análise fatorial identificou quatro dimensões: efetividade da avaliação do estágio probatório, suporte da instituição, ação gerencial e valorização do estágio probatório enquanto avaliação. Em seguida, um modelo de regressão linear estimou o efeito dessas dimensões e das variáveis individuais sobre a percepção da efetividade. Os principais resultados indicam que fatores contextuais exercem maior impacto do que variáveis pessoais, e o suporte da instituição foi a dimensão mais importante.Considerando que el contexto social influye en la efectividad de la evaluación de desempeño (Levy; Williams, 2004) y la escasez del tema en investigaciones científicas, este artículo busca identificar qué factores explican la percepción de la efectividad de la evaluación de la etapa probatoria. La hipótesis es que elementos contextuales son más importantes que variables individuales (Santos, 2005). La encuesta utilizó una encuesta entre el 24 de noviembre y el 30 de diciembre de 2015, con 550 servidores de la Universidad Federal de Pernambuco. El análisis factorial identificó cuatro dimensiones: efectividad de la evaluación de la etapa probatoria, apoyo de la institución, acción gerencial y valorización de la etapa probatoria como evaluación. A continuación, un modelo de regresión lineal estimó el efecto de esas dimensiones y de las variables individuales sobre la percepción de la efectividad. Los principales resultados indican que factores contextuales ejercen mayor impacto que variables personales y el soporte de la institución fue la dimensión más importante.Considering that the social context influences the effectiveness of performance evaluation (Levy; Williams, 2004) and the scarcity of the topic in scientific research, this article seeks to identify which factors explain the perception of the effectiveness of the evaluation of the probationary stage. The hypothesis is that contextual elements are more important than individual variables (Santos, 2005). The survey used a survey between November 24 and December 30, 2015, with 550 servers from the Federal University of Pernambuco. Factor analysis identified four dimensions: evaluation effectiveness of probationary period, institution support, management action and evaluation of probationary period as evaluation. Then, a linear regression model estimated the effect of these dimensions and the individual variables on the perception of effectiveness. The main results indicate that contextual factors have greater impact than personal variables and Institutional Support was the most important dimension.Revista do Serviço Público - RSP, v. 69, n. 3, p.154-182Administração PúblicaGestão de PessoasISSN eletrônico: 2357-8017ISSN impresso: 0034-924

Maternal outcomes and risk factors for COVID-19 severity among pregnant women.

Pregnant women may be at higher risk of severe complications associated with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which may lead to obstetrical complications. We performed a case control study comparing pregnant women with severe coronavirus disease 19 (cases) to pregnant women with a milder form (controls) enrolled in the COVI-Preg international registry cohort between March 24 and July 26, 2020. Risk factors for severity, obstetrical and immediate neonatal outcomes were assessed. A total of 926 pregnant women with a positive test for SARS-CoV-2 were included, among which 92 (9.9%) presented with severe COVID-19 disease. Risk factors for severe maternal outcomes were pulmonary comorbidities [aOR 4.3, 95% CI 1.9-9.5], hypertensive disorders [aOR 2.7, 95% CI 1.0-7.0] and diabetes [aOR2.2, 95% CI 1.1-4.5]. Pregnant women with severe maternal outcomes were at higher risk of caesarean section [70.7% (n = 53/75)], preterm delivery [62.7% (n = 32/51)] and newborns requiring admission to the neonatal intensive care unit [41.3% (n = 31/75)]. In this study, several risk factors for developing severe complications of SARS-CoV-2 infection among pregnant women were identified including pulmonary comorbidities, hypertensive disorders and diabetes. Obstetrical and neonatal outcomes appear to be influenced by the severity of maternal disease

Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection

Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

Summary Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

Fatores que explicam a percepção da efetividade da avaliação do estágio probatório em uma instituição pública federal

Considerando que o contexto social exerce influência sobre a efetividade da avaliação de desempenho (Levy; Williams, 2004) e a escassez do tema em pesquisas científicas, este artigo busca identificar que fatores explicam a percepção da efetividade da avaliação do estágio probatório. A hipótese é de que elementos contextuais são mais importantes do que variáveis individuais (Santos, 2005). A pesquisa utilizou um survey entre 24 de novembro e 30 de dezembro de 2015, com 550 servidores da Universidade Federal de Pernambuco. A análise fatorial identificou quatro dimensões: efetividade da avaliação do estágio probatório, suporte da instituição, ação gerencial e valorização do estágio probatório enquanto avaliação. Em seguida, um modelo de regressão linear estimou o efeito dessas dimensões e das variáveis individuais sobre a percepção da efetividade. Os principais resultados indicam que fatores contextuais exercem maior impacto do que variáveis pessoais, e o suporte da instituição foi a dimensão mais importante.Considerando que el contexto social influye en la efectividad de la evaluación de desempeño (Levy; Williams, 2004) y la escasez del tema en investigaciones científicas, este artículo busca identificar qué factores explican la percepción de la efectividad de la evaluación de la etapa probatoria. La hipótesis es que elementos contextuales son más importantes que variables individuales (Santos, 2005). La encuesta utilizó una encuesta entre el 24 de noviembre y el 30 de diciembre de 2015, con 550 servidores de la Universidad Federal de Pernambuco. El análisis factorial identificó cuatro dimensiones: efectividad de la evaluación de la etapa probatoria, apoyo de la institución, acción gerencial y valorización de la etapa probatoria como evaluación. A continuación, un modelo de regresión lineal estimó el efecto de esas dimensiones y de las variables individuales sobre la percepción de la efectividad. Los principales resultados indican que factores contextuales ejercen mayor impacto que variables personales y el soporte de la institución fue la dimensión más importante.Considering that the social context influences the effectiveness of performance evaluation (Levy; Williams, 2004) and the scarcity of the topic in scientific research, this article seeks to identify which factors explain the perception of the effectiveness of the evaluation of the probationary stage. The hypothesis is that contextual elements are more important than individual variables (Santos, 2005). The survey used a survey between November 24 and December 30, 2015, with 550 servers from the Federal University of Pernambuco. Factor analysis identified four dimensions: evaluation effectiveness of probationary period, institution support, management action and evaluation of probationary period as evaluation. Then, a linear regression model estimated the effect of these dimensions and the individual variables on the perception of effectiveness. The main results indicate that contextual factors have greater impact than personal variables and Institutional Support was the most important dimension.Revista do Serviço Público - RSP, v. 69, n. 3, p.154-182Administração PúblicaGestão de PessoasISSN eletrônico: 2357-8017ISSN impresso: 0034-924

Structural characterization of coagulant Moringa oleifera Lectin and its effect on hemostatic parameters

Lectins are carbohydrate recognition proteins. cMoL, a coagulant Moringa oleifera Lectin, was isolated from seeds of the plant. Structural studies revealed a heat-stable and pH resistant protein with 101 amino acids, 11.67 theoretical pI and 81% similarity with a M. oleifera flocculent protein. Secondary structure content was estimated as 46% alpha-helix, 12% beta-sheets, 17% beta-turns and 25% unordered structures belonging to the alpha/beta tertiary structure class. cMoL significantly prolonged the time required for blood coagulation, activated partial thromboplastin (aPTF) and prothrombin times (PT), but was not so effective in prolonging aPTT in asialofetuin presence. cMoL acted as an anticoagulant protein on in vitro blood coagulation parameters and at least on aPTT, the lectin interacted through the carbohydrate recognition domain. (C) 2013 Elsevier B.V. All rights reserved.Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Univ Fed Pernambuco, Dept Bioquim, BR-50670901 Recife, PE, BrazilUniversidade Federal de São Paulo, Dept Bioquim, BR-04044020 São Paulo, BrazilUniv Estadual Oeste Parana, Ctr Engn & Ciencias Exatas, BR-85903000 Toledo, PR, BrazilLMU, Inst Clin Neuroimmunol, Munich, GermanyMax Planck Inst Biochem, Dept Prot Analyt, D-82152 Martinsried, GermanyUniversidade Federal de São Paulo, Dept Bioquim, BR-04044020 São Paulo, BrazilWeb of Scienc

Development of the SORRI-BAURU posterior walker

This study aimed to report on the design and development of a low cost Reverse Walker through a participative development cycle with people undergoing rehabilitation. The creation and fundamentals of the concept are described, as well as the development of prototypes and their provision to subjects with mobility problems. The Reverse Walker benefits the user by promoting a more upright posture and favoring the development of postural balance. Enhancing the mobility of people with disabilities may benefit their independence, social participation and quality of life

Evolutionary dynamics and dissemination pattern of the SARS-CoV-2 lineage B.1.1.33 during the early pandemic phase in Brazil

We would like to thank the funding support from CGLab/MoH (General Laboratories Coordination of Brazilian Ministry of Health), CVSLR/FIOCRUZ (Coordination of Health Surveillance and Reference Laboratories of Oswaldo Cruz Foundation), CNPq COVID-19 MCTI 402457/2020-0, and INOVA VPPCB-005-FIO20-2Oswaldo Cruz Foundation. Oswaldo Cruz Institute. Laboratory of Respiratory Viruses and Measles. Rio de Janeiro, RJ, Brasil / Brazilian Ministry of Health. Pan-American Health Organization. SARS-CoV-2 National Reference Laboratory. Regional Reference Laboratory in Americas. Rio de Janeiro, RJ, Brazil.Universidade Federal do Espírito Santo - Campus de Alegre. Centro de Ciências Exatas, Naturais e da Saude. Departamento de Biologia. Vitória, ES, Brazil.Fundação Oswaldo Cruz. Gonçalo Moniz. Salvador, BA, Brazil.Universidad de la Republica. Centro Universitario Regional del Litoral Norte. Unidad de Genomica y Bioinformatica. Salto, Uruguay.Oswaldo Cruz Foundation. Oswaldo Cruz Institute. Laboratory of Respiratory Viruses and Measles. Rio de Janeiro, RJ, Brasil / Brazilian Ministry of Health. Pan-American Health Organization. SARS-CoV-2 National Reference Laboratory. Regional Reference Laboratory in Americas. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Oswaldo Cruz Institute. Laboratory of Respiratory Viruses and Measles. Rio de Janeiro, RJ, Brasil / Brazilian Ministry of Health. Pan-American Health Organization. SARS-CoV-2 National Reference Laboratory. Regional Reference Laboratory in Americas. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Oswaldo Cruz Institute. Laboratory of Respiratory Viruses and Measles. Rio de Janeiro, RJ, Brasil / Brazilian Ministry of Health. Pan-American Health Organization. SARS-CoV-2 National Reference Laboratory. Regional Reference Laboratory in Americas. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Oswaldo Cruz Institute. Laboratory of Respiratory Viruses and Measles. Rio de Janeiro, RJ, Brasil / Brazilian Ministry of Health. Pan-American Health Organization. SARS-CoV-2 National Reference Laboratory. Regional Reference Laboratory in Americas. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Oswaldo Cruz Institute. Laboratory of Respiratory Viruses and Measles. Rio de Janeiro, RJ, Brasil / Brazilian Ministry of Health. Pan-American Health Organization. SARS-CoV-2 National Reference Laboratory. Regional Reference Laboratory in Americas. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Oswaldo Cruz Institute. Laboratory of Respiratory Viruses and Measles. Rio de Janeiro, RJ, Brasil / Brazilian Ministry of Health. Pan-American Health Organization. SARS-CoV-2 National Reference Laboratory. Regional Reference Laboratory in Americas. Rio de Janeiro, RJ, Brazil.Fundação Oswaldo Cruz. Instituto Aggeu Magalhaes. Recife, PE, Brazil.Fundação Oswaldo Cruz. Instituto Aggeu Magalhaes. Recife, PE, Brazil.Ministério da Saúde. Secretaria de Vigilância em Saúde. Instituto Evandro Chagas. Ananindeua, PA, Brasil.Ministério da Saúde. Secretaria de Vigilância em Saúde. Instituto Evandro Chagas. Ananindeua, PA, Brasil.Ministério da Saúde. Secretaria de Vigilância em Saúde. Instituto Evandro Chagas. Ananindeua, PA, Brasil.Ministério da Saúde. Secretaria de Vigilância em Saúde. Instituto Evandro Chagas. Ananindeua, PA, Brasil.Laboratorio Central de Saude Publica do Estado de Santa Catarina. Florianopolis, SC, Brazil.Laboratorio Central de Saude Publica do Estado Espirito Santo. Vitoria, ES, Brazil.Laboratorio Central de Saude Publica do Distrito Federal. Brasília, DF, Brazil.Laboratorio Central de Saude Publica de Alagoas. Maceio, AL, Brazil.Laboratorio Central de Saude Publica da Bahia. Salvador, BA, Brazil.Laboratorio Central de Saude Publica de Sergipe. Aracaju, SE, Brazil.Laboratorio Central de Saude Publica de Parana. Curitiba, PR, Brazil.Laboratorio Central de Saude Publica de Parana. Curitiba, PR, Brazil.Fundação Oswaldo Cuz - Mato Grosso do Sul. Campo Grande, MT, Brazil / Universidade Federal de Mato Grosso do Sul. Campo Grande, MT, Brazil.Ministério da Defesa. Hospital das Forças Armadas. Brasília, DF, Brazil.Ministério da Saude. Coordenadoria Geral de Laboratorios. Brasília, DF, Brazil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratorio de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Oswaldo Cruz Institute. Laboratory of Respiratory Viruses and Measles. Rio de Janeiro, RJ, Brasil / Brazilian Ministry of Health. Pan-American Health Organization. SARS-CoV-2 National Reference Laboratory. Regional Reference Laboratory in Americas. Rio de Janeiro, RJ, Brazil.A previous study demonstrates that most of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Brazilian strains fell in three local clades that were introduced from Europe around late February 2020. Here we investigated in more detail the origin of the major and most widely disseminated SARS-CoV-2 Brazilian lineage B.1.1.33. We recovered 190 whole viral genomes collected from 13 Brazilian states from February 29 to April 31, 2020 and combined them with other B.1.1 genomes collected globally. Our genomic survey confirms that lineage B.1.1.33 is responsible for a variable fraction of the community viral transmissions in Brazilian states, ranging from 2% of all SARS-CoV-2 genomes from Pernambuco to 80% of those from Rio de Janeiro. We detected a moderate prevalence (5-18%) of lineage B.1.1.33 in some South American countries and a very low prevalence (<1%) in North America, Europe, and Oceania. Our study reveals that lineage B.1.1.33 evolved from an ancestral clade, here designated B.1.1.33-like, that carries one of the two B.1.1.33 synapomorphic mutations. The B.1.1.33-like lineage may have been introduced from Europe or arose in Brazil in early February 2020 and a few weeks later gave origin to the lineage B.1.1.33. These SARS-CoV-2 lineages probably circulated during February 2020 and reached all Brazilian regions and multiple countries around the world by mid-March, before the implementation of air travel restrictions in Brazil. Our phylodynamic analysis also indicates that public health interventions were partially effective to control the expansion of lineage B.1.1.33 in Rio de Janeiro because its median effective reproductive number (R e ) was drastically reduced by about 66% during March 2020, but failed to bring it to below one. Continuous genomic surveillance of lineage B.1.1.33 might provide valuable information about epidemic dynamics and the effectiveness of public health interventions in some Brazilian states

Núcleos de Ensino da Unesp: artigos 2010: volume 4: as disciplinas escolares, os temas transversais e o processo de educação

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP